Suggestions
Zsolt Talloczy
Director of Clinical Development at Novartis
Zsolt Talloczy is a pharmaceutical professional with a diverse background in leadership roles spanning pre-clinical to clinical research.
He possesses in-depth expertise in neuroscience, infectious diseases, and immunology, stemming from his academic research experience with a team of technicians and junior scientists at Columbia University.
Zsolt has a strong track record in global clinical development, having handled various phases of studies from design to completion in fields like neuroscience, dermatology, and rheumatology.
With a rich publication history, he has authored 18 scientific papers in prestigious biomedical journals and books.
His experience also includes drug regulatory affairs work on a global scale, showcasing his comprehensive knowledge of pharmaceutical processes and regulations.
In terms of education, Zsolt has a diverse academic background, ranging from studying Tennis at Central Sport School to pursuing postdoctoral training in Molecular and Cell Biology at Columbia University.
He holds a PhD in Microbiology and Molecular Genetics from Rutgers University and an MS in Chemical Engineering and Biotechnology from Budapest University of Technology and Economics.
Currently, Zsolt Talloczy serves as the Director of Clinical Development at Novartis, bringing his wealth of experience to lead and oversee strategic initiatives in the pharmaceutical industry.
His past roles at Novartis include positions such as Associate Director in Clinical Sciences and various Senior Clinical Management positions, indicating his progression and significant contributions within the organization.
Zsolt has also served as a Research Scientist at Columbia University Medical Center, further enriching his research and practical experience in the field.
With dual US and EU citizenship, Zsolt Talloczy has a global perspective and understanding of pharmaceutical development and regulatory landscapes.
